A detailed history of Equitable Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Equitable Trust CO holds 21,270 shares of AMGN stock, worth $6.71 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
21,270
Previous 19,073 11.52%
Holding current value
$6.71 Million
Previous $5.42 Million 22.56%
% of portfolio
0.48%
Previous 0.39%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$262.75 - $319.31 $577,261 - $701,524
2,197 Added 11.52%
21,270 $6.65 Million
Q1 2024

Apr 25, 2024

BUY
$268.87 - $324.56 $1.86 Million - $2.24 Million
6,900 Added 56.68%
19,073 $5.42 Million
Q4 2023

Jan 25, 2024

BUY
$255.7 - $288.46 $2.57 Million - $2.9 Million
10,064 Added 477.19%
12,173 $3.51 Million
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $15,961 - $19,816
73 Added 3.59%
2,109 $566,000
Q1 2023

May 08, 2023

SELL
$225.79 - $275.2 $26,191 - $31,923
-116 Reduced 5.39%
2,036 $492,000
Q4 2022

Feb 21, 2023

BUY
$229.03 - $291.01 $54,738 - $69,551
239 Added 12.49%
2,152 $565,000
Q2 2022

Jul 15, 2022

BUY
$230.71 - $256.74 $25,608 - $28,498
111 Added 6.16%
1,913 $465,000
Q1 2022

May 06, 2022

SELL
$219.27 - $242.57 $2,631 - $2,910
-12 Reduced 0.66%
1,802 $436,000
Q4 2021

Jan 31, 2022

BUY
$198.88 - $227.6 $795 - $910
4 Added 0.22%
1,814 $408,000
Q3 2021

Oct 26, 2021

SELL
$212.27 - $248.7 $964,342 - $1.13 Million
-4,543 Reduced 71.51%
1,810 $385,000
Q2 2021

Aug 03, 2021

SELL
$233.58 - $259.14 $96,001 - $106,506
-411 Reduced 6.08%
6,353 $1.55 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $119,387 - $139,126
538 Added 8.64%
6,764 $1.68 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $74,218 - $88,380
343 Added 5.83%
6,226 $1.43 Million
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $5,631 - $6,262
24 Added 0.41%
5,883 $1.5 Million
Q1 2020

May 21, 2020

BUY
$182.24 - $241.7 $692,329 - $918,218
3,799 Added 184.42%
5,859 $1.19 Million
Q4 2019

Feb 18, 2020

BUY
$189.21 - $243.2 $24,975 - $32,102
132 Added 6.85%
2,060 $497,000
Q3 2019

Nov 19, 2019

BUY
$174.11 - $208.62 $43,005 - $51,529
247 Added 14.69%
1,928 $373,000
Q2 2019

Aug 16, 2019

SELL
$166.7 - $195.41 $21,504 - $25,207
-129 Reduced 7.13%
1,681 $309,000
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $73,433 - $82,775
406 Added 28.92%
1,810 $343,000
Q4 2018

Feb 22, 2019

SELL
$178.4 - $208.25 $7,314 - $8,538
-41 Reduced 2.84%
1,404 $274,000
Q3 2018

Nov 15, 2018

SELL
$185.29 - $208.89 $414,123 - $466,869
-2,235 Reduced 60.73%
1,445 $299,000
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $611,064 - $686,356
3,680 New
3,680 $680,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Equitable Trust CO Portfolio

Follow Equitable Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.